<i>Dual Specificity Phosphatase</i> (<i>DUSP22</i>) promoter hypomethylation in cell-free DNA is associated with rheumatoid arthritis and its radiographic severity.

ABSTRACT:

Objectives

While several advances have been made in the last decade, reliable biomarkers for disease activity, prognosis, and response to treatment of rheumatoid arthritis (RA) have yet to be identified. In previous studies, DUSP22 DNA methylation changes were found to be associated with RA and erosive disease. We conducted a pilot study to investigate plasma cell-free DNA (cfDNA) methylation in DUSP22 in a cohort of RA patients and healthy controls. We also investigate DUSP22 DNA methylation associations with RA clinical characteristics and treatment.

Methods

DNA was isolated from plasma from 27 RA patients who satisfied the ACR criteria, and 18 healthy controls. DUSP22 DNA methylation was determined by pyrosequencing. Statistical analysis identi

SUBMITTER: Delgado-Cruzata L 

PROVIDER: S-EPMC12909564 | biostudies-literature | 2026

REPOSITORIES: biostudies-literature